These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1077 related items for PubMed ID: 25504382
1. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk]. Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN, Naceur B. Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382 [Abstract] [Full Text] [Related]
2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [Abstract] [Full Text] [Related]
3. Thalassemic osteopathy: a new marker of bone deposition. Baldini M, Forti S, Orsatti A, Marcon A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD. Blood Cells Mol Dis; 2014 Mar; 52(2-3):91-4. PubMed ID: 24091145 [Abstract] [Full Text] [Related]
4. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study. Zhao J, Xia W, Nie M, Zheng X, Wang Q, Wang X, Wang W, Ning Z, Huang W, Jiang Y, Li M, Wang O, Xing X, Sun Y, Luo L, He S, Yu W, Lin Q, Pei Y, Zhang F, Han Y, Tong Y, Che Y, Shen R, Hu Y, Zhou X, Xu L. Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303 [Abstract] [Full Text] [Related]
6. Relationship of bone turnover to bone density and fractures. Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL. J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008 [Abstract] [Full Text] [Related]
7. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China. Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL. Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899 [Abstract] [Full Text] [Related]
8. Elevated Bone Turnover Markers Are Associated With Distal Radius Fractures in Premenopausal Women. Ting BL, Walley KC, Travison TG, Rozental TD. J Hand Surg Am; 2017 Feb; 42(2):71-77. PubMed ID: 28160903 [Abstract] [Full Text] [Related]
9. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA. J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717 [Abstract] [Full Text] [Related]
10. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men. Shou Z, Jin X, Bian P, Li X, Chen J. Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883 [Abstract] [Full Text] [Related]
11. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD. J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854 [Abstract] [Full Text] [Related]
12. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E. J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563 [Abstract] [Full Text] [Related]
13. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC. Osteoporos Int; 2000 Feb; 11(4):295-303. PubMed ID: 10928218 [Abstract] [Full Text] [Related]
14. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. Reginster JY, Sarkar S, Zegels B, Henrotin Y, Bruyere O, Agnusdei D, Collette J. Bone; 2004 Feb; 34(2):344-51. PubMed ID: 14962813 [Abstract] [Full Text] [Related]
15. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover. Delmas PD, Licata AA, Reginster JY, Crans GG, Chen P, Misurski DA, Wagman RB, Mitlak BH. Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890 [Abstract] [Full Text] [Related]
16. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis. Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE. Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460 [Abstract] [Full Text] [Related]
17. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH. Bone; 2010 Apr 20; 46(4):935-9. PubMed ID: 20060081 [Abstract] [Full Text] [Related]
18. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD. J Bone Miner Res; 2002 May 20; 17(5):826-33. PubMed ID: 12009013 [Abstract] [Full Text] [Related]
19. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women. Botella S, Restituto P, Monreal I, Colina I, Calleja A, Varo N. J Clin Endocrinol Metab; 2013 Nov 20; 98(11):E1740-8. PubMed ID: 24001743 [Abstract] [Full Text] [Related]
20. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women. Kharroubi A, Saba E, Smoom R, Bader K, Darwish H. Arch Osteoporos; 2017 Dec 20; 12(1):13. PubMed ID: 28124221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]